carbenoxolone sodium has been researched along with Cirrhosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fuller, PJ; Funder, JW; Morgan, J; Wilson, P; Young, MJ | 1 |
Ariga, H; Egawa, S; Hamada, S; Hayashi, S; Hirota, M; Kanno, A; Kikuta, K; Kume, K; Masamune, A; Shimosegawa, T; Suzuki, N; Takikawa, T; Unno, M | 1 |
Acharya, V; Ayyalasomayajula, V; Koppala, SR; Nemani, H; Ponday, LR; Pothana, S; Prasad Sakamuri, SS; Prathipati, VK; Putcha, UK; Sukapaka, M; Veetill, GN | 1 |
Dilley, R; Funder, JW; Moussa, L; Young, MJ | 1 |
4 other study(ies) available for carbenoxolone sodium and Cirrhosis
Article | Year |
---|---|
Mediators of mineralocorticoid receptor-induced profibrotic inflammatory responses in the heart.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Animals; Carbenoxolone; Cardiomegaly; Endothelium, Vascular; Enzyme Inhibitors; Fibrosis; Macrophages; Male; Myocarditis; Myocardium; Nitric Oxide; Osteopontin; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2009 |
Connexins regulate cell functions in pancreatic stellate cells.
Topics: Animals; Becaplermin; Blotting, Western; Carbenoxolone; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen Type I; Connexin 43; Connexins; Dose-Response Relationship, Drug; Fibrosis; Fluorescent Antibody Technique; Humans; Male; Myofibroblasts; Pancreatic Neoplasms; Pancreatic Stellate Cells; Pancreatitis, Chronic; Proto-Oncogene Proteins c-sis; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; RNA, Small Interfering | 2013 |
Carbenoxolone treatment ameliorated metabolic syndrome in WNIN/Ob obese rats, but induced severe fat loss and glucose intolerance in lean rats.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adipocytes; Adipose Tissue; Adrenal Glands; Animals; Body Composition; Carbenoxolone; Cholesterol, HDL; Corticosterone; Eating; Enzyme Inhibitors; Fibrosis; Gene Expression Regulation; Glucose Intolerance; Glycogen; Hypertrophy; Liver; Male; Metabolic Syndrome; Obesity; Organ Size; Rats; Signal Transduction; Thinness; Triglycerides | 2012 |
Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivation.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Animals; Blood Pressure; Carbenoxolone; Cardiomegaly; Coronary Disease; Desoxycorticosterone; Enzyme Inhibitors; Eplerenone; Fibrosis; Heart; Hydroxysteroid Dehydrogenases; Kidney; Male; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Myocardium; Nephrectomy; Organ Size; Rats; Rats, Sprague-Dawley; Sodium Chloride; Solutions; Spironolactone; Vasculitis | 2003 |